Products for Research Use Only
RegisterLogin

Tepoditamab

CAT: 0931-T76880-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T76880-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2044679-53-8
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Bioactivity
Tepoditamab (MCLA-117) is a bispecific monoclonal antibody targeting CLEC12A on myeloid cells and CD3 on cytotoxic T cells. As a myeloid differentiation antigen, CLEC12A allows the compound to eliminate AML leukemia progenitor and stem cells through T cell-mediated proliferative lysis, making it valuable in acute myeloid leukemia (AML) research [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
HY-P99390-01Tepoditamab
GTR18337896-01Tepoditamab Antibody
MBS1563987-01Research Grade Tepoditamab
E55B1234Tepoditamab (Reference antibody)
592244Tepoditamab (CD3E, CLEC12A)
KBI1770KRIBIOLISA™ Tepoditamab ELISA
C00334-01Tepoditamab (Anti-CLEC12A / CD371)
048034CLEC12A/CD371 (tepoditamab) discontinued
ABS-382-100ugTepoditamab Biosimilar, Research Grade
GTR18697704-01Tepoditamab Human Monoclonal Antibody

Popular Products